Suchergebnisse - "Xu, Yu-Hang"

PubPharm (12)

1

Nitrogen-doped titanium dioxide/schwertmannite nanocomposites as heterogeneous photo-Fenton catalysts with enhanced efficiency for the degradation of bisphenol A

enthalten in: Journal of environmental sciences (China) | 2024

von Qiao, X. | Xu, Y. | Liu, X. | +4

2

Iron-doped bismuth oxybromides as visible-light-responsive Fenton catalysts for the degradation of atrazine in aqueous phases

enthalten in: Journal of environmental sciences (China) | 2024

von Cai, Y. | Xu, Y. | Xiang, J. | +4

3

Urantide alleviates atherosclerosis-related liver and kidney injury via the Wnt/β-catenin signaling pathway in ApoE(-/-) mice

enthalten in: Herz | 2023

von Xu, Y. | Xie, J. | Huang, S. | +3

4

A Novel Molecular Reservoir Based on Reverse Self-Assembled Liquid Crystals - A New Strategy for Prolonging the Duration in Action of Analgesics

enthalten in: Journal of pharmaceutical sciences | 2023

von Cao, W. | Chen, J. | Wu, L. | +5

5

Microstructural and Mechanical Properties of Aluminum Matrix Composite Reinforced with Cu-Zn-Al Particles Fabricated by Friction Stir Processing

enthalten in: Transactions of the Indian Institute of Metals | 2022

von Yang, L. | Lu, K. | Liu, Z. | +4

6

Microstructural and Mechanical Properties of Aluminum Matrix Composite Reinforced with Cu-Zn-Al Particles Fabricated by Friction Stir Processing

enthalten in: Transactions of the Indian Institute of Metals | 2022

von Yang, L. | Lu, K. | Liu, Z. | +4

7

Photocatalytic CO2-to-Ethylene Conversion over Bi2S3/CdS Heterostructures Constructed via Facile Cation Exchange

enthalten in: Research (Washington, D.C.) | 2022

von Huang, H. | Zhang, N. | Xu, J. | +4

8

A review of current progress in triple-negative breast cancer therapy

enthalten in: Open medicine | 2020

von Shen, M. | Pan, H. | Chen, Y. | +3

9

A review of current progress in triple-negative breast cancer therapy

enthalten in: Open medicine (Warsaw, Poland) | 2020

von Shen, M. | Pan, H. | Chen, Y. | +3

10

A review of current progress in triple-negative breast cancer therapy

in: Open Medicine | 2020

von Shen Meiying | Pan Huawen | Chen Yuxia | +3